Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture

Cancer Research

Volumn 60, Issue 3, 2000, Pages 610-617

  Engelhardt, Monika ^a,c   Mackenzie, Karen ^a   Drullinsky, Pamela ^a   Silver, Richard T ^b   Moore, Malcolm A S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TELOMERASE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHRONIC LEUKEMIA; CORRELATION FUNCTION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEM CELL; TELOMERE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 0033973802     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Blackburn, E. H. Structure and function of telomeres. Nature (Lond.), 266: 569-573, 1991.
2. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., and Landsdorp, P. M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA, 91: 9857-9860, 1994.
3. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
4. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., and Harley, C. B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 10114-10118, 1992.
5. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
6. Counter, C. M., Hirte, H. W., Bacchetti, S., and Harley, C. B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91: 2900-2904, 1994.
7. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-255, 1995.
8. Engelhardt, M., Albanell, J., Drullinsky, P., Han, W., Guillem, J., Scher, H., Reuter, V., and Moore, M. A. S. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon and sarcoma. Clin. Cancer Res., 3: 1849-1857, 1997.
9. Engelhardt, M., Drulinsky, P., Guillem, J., and Moore, M. A. S. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res., 3: 1931-1941, 1997.
10. Albanell, J., Leonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M. A. S, and Dmitrovsky, E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst., 89: 1609-1615, 1997.
11. Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A. B., Wright, W. E., and Shay, J. W. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res., 2: 799-803, 1996.
12. Counter, C. M., Gupta, J., Harley, C. B., Leber, B., Bacchetti, S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 81: 2315-2320, 1995.
13. Engelhardt, M., Kumar, R., Albanell, J., Pettengell, R., Han, W., and Moore, M. A. S. Telomerase regulation, cell cycle and telomere stability in primitive hematopoietic cells. Blood, 90: 182-193, 1997.
14. Igarashi, H., Sakaguchi, N. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood, 89: 1299-1307, 1997.
15. Moore, M. A. S. Stem cell proliferation: ex vivo and in vivo observations. Stem Cells, 15(Suppl. 1): 239-248, 1997.
16. Löwenberg, B., Touw I. P. Hematopoietic growth factors and their receptors in acute leukemia. Blood, 81: 281-292, 1983.
17. Albanell, J., Han, W., Mellado, B., Gunawardane, R., Scher, H. I., Dmitrovsky, E., and Moore, M. A. S. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res., 56: 1503-1508, 1996.
18. Dmitrovsy, E. N-(4-hydroxyphenyl)retinamide activation of a distict pathway signaling apoptosis. J. Natl. Cancer Inst. 89: 1179-1181, 1997.
19. Petzer, A. L., Eaves, C. J., Barnett, M. J., and Eaves, A. C. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood, 90: 64-69, 1997.
20. + cells from patients with chronic myeloid leukemia. Blood, 88: 1796-1804, 1996.
21. Coutinho, L. H., Brereton, M. L., Santos, A. M. W., Ryder, W. D. J., Chang, J., Harrison, C. J., Liu Yin, J. A., Dexter, T. M., and Testa, N. G. Evaluation of cytogenetic conversion to Ph hematopoiesis in long-term bone marrow culture for patients with chronic myeloid leukemia on conventional hydroxyurea therapy, on pulse high-dose hydroxyurea and on interferon-α. Br. J. Haematol., 93: 869-877, 1996.
22. Shay, J. W., Werbin, H., and Wright, W. E. Telomeres and telomerase in human leukemias. Leukemia (Baltimore), 10: 1255-1261, 1996.
23. Ohyashiki, J. H., Ohyashiki, K., Iwama, H., Hayashi, S., Toyama, K., and Shay, J. W. Clinical implications of telomerase activity levels in acute leukemia. Clin. Cancer Res., 3: 619-625, 1997.
24. Ohyashiki, K., Ohyashiki, J. H., Iwama, H., Hayashi, S., Shay, J. W., and Toyama, K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia (Baltimore), 11: 190-194, 1997.
25. Engelhardt, M., Ozkaynak, M. F., Drullinsky, P., Sandoval, C., Tugal, O., Jayabose, S., and Moore, M. A. S. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia (Baltimore), 12: 13-24, 1998.
26. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17: 1-15, 1995.
27. Wright, E. W., Shay, J. W., and Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
28. Kim, N. W., and Wu, F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res., 25: 2595-2597, 1997.
29. Mehle, C., Ljungberg, B., and Roos, G. Telomere shortening in renal cell carcinoma. Cancer Res., 54: 236-241, 1994.
30. Harley, C. B., Futcher, A. B., and Greider, C. W. Telomeres shortening during ageing of human fibroblasts. Nature (Lond.), 345: 458-460, 1990.
31. Iwama, H., Ohyashiki, K., Ohyashiki, J. H., Hayashi, S., Kawabubo, K., Shay, J. W., and Toyama, K. The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer (Phila.). 79: 1552-1560, 1997.
32. Seol, J. G., Kim, E. S., Park, W. H., Jung, C. W., Kim, B. K., and Lee, Y. Y. Telomerase activity in acute myelogenous leukemia: clinical and biological implications. Br. J. Haematol., 100: 156-165, 1998.
33. Ohyashiki, J. H., Ohyashiki, K., Fujimura, T., Kawakubo, K., Shimamoto, T., Iwabuchi, A., and Toyama, K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res., 54: 3557-3560, 1994.
34. Boultwood, J., Fidler, C., Kusec, R., Rack, K., Elliott, P. J. W., Atoyebi, O., Chapman, R., Oscier, D. G., and Wainscoat, J. S. Telomere length in myelodysplastic syndromes. Am. J. Hematol., 56: 266-271, 1997.
35. Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C., and Gordon-Smith, E. C. Progressive telomere shortening in aplastic anemia. Blood, 91: 3582-3592, 1998.
36. Jeanclos, E., Krolewski, A., Skurnick, J., Kimura, M., Aviv, H., Warram, J. H., and Aviv, A. Shortened telomere length in white blood cells of patients with IDDM. Diabetes, 47: 482-486, 1998.
37. Artlett, C. M., Black, C. M., Briggs, D. C., Stevens, C. O., and Welsh, K. I. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol., 35: 732-737, 1996.
38. Akiyama, M., Hoshi, Y., Sakurai, S., Yamada, H., Yamada, O., and Mizoguchi, H. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant., 21: 167-171, 1998.
39. Wynn, R. F., Cross, M. A., Hatton, C., Will, A. M., Lashford, L. S., Dexter, T. M., and Testa, N. G. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet, 351: 178-181, 1998.
40. Notaro, R., Cimmino, A., Tabarini, D., Rotoli, B., and Luzzatto, L. In vivo telomere dynamics of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 94: 13782-13785, 1997.
41. Ishibashi, T., and Lippard, S. J. Telomere loss in cells treated with cisplatin. Proc. Nail. Acad. Sci. USA, 95: 4219-4223, 1998.
42. Engelhardt, M., Schmidt, G., Lindemann, A., and Mertelsmann, R. Telomere length shortening in adult tumor patients undergoing standard or intensified chemo- and radiotherapy. Blood 92(Suppl. 1): 228a, 1998.
43. Soligo, D. A., Lambertenghi Deliliers, G., Servida, F., Quirici, N., Campiglio, S., Tagliaferri, E., Oriani, A., Romitti, L., Della Volpe, A., and Annaloro, C. Hematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplant., 21: 15-22, 1998.
44. Podesta, M., Piaggio, G., Frassoni, F., Pitto, A., Mordini, N., Bregante, S., Valeriani, A., and Bacigalupo, A. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant., 19: 1011-1017, 1997.
45. Sawyers, C. L., Gishizki, M. L., Quan, S., Golde, D. W., and Witte, O. N. Propagation of human blastic myeloid leukemias in the SCID mouse. Blood, 79: 2089-2098, 1992.
46. Sirard, C. Lapidot, T., Vormoor, J., Cashman, J. D., Doedens, M., Murdoch, B., Jamal, N., Messner, H., Addey, L., Minden, M., Laraya, P., Keating, A., Eaves, A., Lansdorp, P. M., Eaves, C. J., and Dick, J. E. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood, 87: 1539-1548, 1996.
47. Khouri, I., Sanchez, F. G., and Deisseroth, A. Acute Leukemias. In: V. T. DeVita, S. Hellmann, and S. A. Rosenberg (eds). Cancer: Principles and Practice of Oncology. New York: Lippincott-Raven, 1997.
48. Blasco, M. A., Lee, H-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R., and Greider, C. W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91: 25-34, 1997.
49. Lee, H-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Jr., Greider, C. W., and DePinho, R. A. Essential role of telomerase in highly proliferative organs. Nature (Lond.), 392: 569-574, 1998.
50. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel R. R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14: 4240-4248, 1996.
51. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. K. M., Meyerson, M., and Weinberg R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med., 5: 1164-1170, 1999.